James Parsons
Vermögen: 577 743 $ am 31.05.2026
Vermögen: 577 743 $ am 31.05.2026
Mr. James T.
Parsons, CPA, is a Chief Financial Officer & Director at Sernova Biotherapeutics, Inc. and a Chairman at DiaMedica Therapeutics, Inc. He is on the Board of Directors at Oncolytics Biotech, Inc. and Sernova Biotherapeutics, Inc. Mr. Parsons was previously employed as a Chief Financial & Accounting Officer by Trillium Therapeutics, Inc., a Chief Financial Officer by Amorfix Life Sciences Ltd., a Chief Financial Officer & Secretary by Trillium Therapeutics, Inc. /Old/, a Vice President-Finance & Administration by Lorus Therapeutics, Inc., and a Controller & Assistant Treasurer by Timminco Ltd. He also served on the board at YM BioSciences, Inc. He received his graduate degree from The University of Waterloo.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 75’854 ( -.--% ) | 454 365 $ | 31.05.2026 | |
| 14.04.2026 | 614’605 ( 0.18% ) | 66 377 $ | 31.05.2026 | |
| 01.06.2026 | 41’849 ( 0.04% ) | 43 523 $ | 31.05.2026 | |
| 01.06.2026 | 2’250 ( 0% ) | 13 478 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Vorsitzender | 01.01.2025 |
| SERNOVA BIOTHERAPEUTICS INC | Finanzdirektor/CFO | 11.10.2024 |
| ONCOLYTICS BIOTECH INC. | Direktor/Vorstandsmitglied | 16.06.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| TRILLIUM THERAPEUTICS | Finanzdirektor/CFO | 17.11.2021 |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Finanzdirektor/CFO | 06.06.2014 |
| PROMIS NEUROSCIENCES, INC. | Finanzdirektor/CFO | 20.10.2010 |
| APTOSE BIOSCIENCES INC. | Finanzdirektor/CFO | 01.01.2003 |
| TIMMINCO LIMITED | Comptroller/Controller/Auditor | 01.01.2000 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Aptose Biosciences, Inc.
Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Timminco Ltd.
Timminco Ltd. Metal FabricationProducer Manufacturing Manufactures specialty magnesium, calcium and strontium alloys | Producer Manufacturing |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
The University of Waterloo
The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen